{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:12:56Z","timestamp":1790921576153,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jcin.2016.12.002","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T15:20:52Z","timestamp":1488813652000},"page":"462-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"title":["Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents"],"prefix":"10.1016","volume":"10","author":[{"given":"Georges","family":"El-Hayek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripal","family":"Bangalore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Casso Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Devireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kreton","family":"Mavromatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tamis-Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Samady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2016.12.002_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2016.12.002_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study","volume":"125","author":"R\u00e4ber","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.12.002_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCINTERVENTIONS.112.970970","article-title":"Stent thrombosis: no\u00a0longer an issue with newer-generation drug-eluting stents?","volume":"5","author":"Stefanini","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.12.002_bib4","first-page":"330","article-title":"Stent thrombosis with second- versus first-generation drug-eluting stents in real-world percutaneous coronary intervention: analysis of 3806 consecutive procedures from a large-volume single-center prospective registry","volume":"25","author":"Dores","year":"2013","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jcin.2012.02.014","article-title":"Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study","volume":"5","author":"Naidu","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.12.002_bib6","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib7","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","article-title":"In-stent neoatherosclerosis: a final common pathway of late stent failure","volume":"59","author":"Park","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jcin.2009.01.004","article-title":"Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?","volume":"2","author":"Finn","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.12.002_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","article-title":"Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project","volume":"47","author":"Nebeker","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib11","doi-asserted-by":"crossref","first-page":"F28","DOI":"10.4244\/EIJV5IFA5","article-title":"The bioabsorption process: tissue and cellular mechanisms and outcomes","volume":"5 Suppl F","author":"Vorpahl","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.12.002_bib12","doi-asserted-by":"crossref","first-page":"f6530","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis","volume":"347","author":"Navarese","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2016.12.002_bib13","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/eurheartj\/ehs086","volume":"33","author":"Stefanini","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2016.12.002_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/eht570","article-title":"Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis","volume":"35","author":"Kang","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2016.12.002_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib16","doi-asserted-by":"crossref","first-page":"f6625","DOI":"10.1136\/bmj.f6625","article-title":"Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis","volume":"347","author":"Bangalore","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2016.12.002_bib17","unstructured":"Higgins JPT, Altman DG, Sterne JAC, editors. Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available at: http:\/\/www.cochrane-handbook.org\/. Accessed August 22, 2016."},{"key":"10.1016\/j.jcin.2016.12.002_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2016.12.002_bib19","unstructured":"Deeks JJ, Higgins JPT, Altman DG, editors. Chapter 9: analyzing data and undertaking meta-analyses. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available at: www.cochrane-handbook.org. Accessed August 22, 2016."},{"key":"10.1016\/j.jcin.2016.12.002_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.114.013520","article-title":"Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivit\u00e4ts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial","volume":"131","author":"Kaiser","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.12.002_bib21","doi-asserted-by":"crossref","first-page":"e001441","DOI":"10.1161\/CIRCINTERVENTIONS.114.001441","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial","volume":"8","author":"Windecker","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.12.002_bib22","doi-asserted-by":"crossref","first-page":"e003255","DOI":"10.1161\/JAHA.116.003255","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial","volume":"4","author":"Zbinden","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcin.2016.12.002_bib23","first-page":"1092","article-title":"Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial","volume":"87","author":"Orvin","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.12.002_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4244\/EIJV11I3A53","volume":"11","author":"Vlachojannis","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.12.002_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4244\/EIJY14M05_03","article-title":"DESSOLVE II randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial","volume":"10","author":"Wijns","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.12.002_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","article-title":"Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"65","author":"Puricel","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4244\/EIJV9I3A52","article-title":"Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent","volume":"9","author":"Meredith","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.12.002_bib28","doi-asserted-by":"crossref","first-page":"e002372","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","article-title":"Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II randomized trial","volume":"8","author":"Kereiakes","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.12.002_bib29","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4244\/EIJY14M11_02","article-title":"Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial","volume":"11","author":"Kufner","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.12.002_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCINTERVENTIONS.113.000841","article-title":"Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial","volume":"7","author":"Lee","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.12.002_bib31","doi-asserted-by":"crossref","first-page":"e002817","DOI":"10.1161\/CIRCINTERVENTIONS.115.002817","article-title":"Final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: NOBORI biolimus-eluting versus XIENCE\/PROMUS Everolimus-Eluting Stent trial","volume":"8","author":"Natsuaki","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.12.002_bib32","first-page":"113","article-title":"The twelve-month outcome of biolimus eluting stent with biodegradable polymer compared with an everolimus eluting stent with durable polymer","volume":"3","author":"Separham","year":"2011","journal-title":"J\u00a0Cardiovasc Thorac Res"},{"key":"10.1016\/j.jcin.2016.12.002_bib33","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(14)61794-3","article-title":"Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial","volume":"385","author":"Raungaard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2016.12.002_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4244\/EIJV9I1A12","article-title":"A\u00a0randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial","volume":"9","author":"Gao","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.12.002_bib35","first-page":"811","volume":"124","author":"Xu","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jcin.2016.12.002_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00239417","article-title":"Biocompatibility of biodegradable and nonbiodegradable polymer-coated stents implanted in porcine peripheral arteries","volume":"18","author":"De Scheerder","year":"1995","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib37","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"Van der Giessen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.12.002_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2016.12.002_bib39","doi-asserted-by":"crossref","first-page":"e002427","DOI":"10.1161\/CIRCINTERVENTIONS.115.002427","article-title":"Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents","volume":"8","author":"Koppara","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.12.002_bib40","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.12.002_bib41","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.jacc.2016.03.475","article-title":"Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: the PANDA\u00a0III\u00a0trial","volume":"67","author":"Xu","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.12.002_bib42","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816322087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816322087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:04:40Z","timestamp":1761847480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879816322087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1936879816322087"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2016.12.002","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}